Vera Therapeutics, Inc. (VERA)
26.97
-1.13
(-4.02%)
USD |
NASDAQ |
Nov 16, 16:00
26.97
0.00 (0.00%)
After-Hours: 19:05
Vera Therapeutics EPS Diluted (Quarterly) : -1.299 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -1.299 |
| June 30, 2026 | -1.524 |
| March 31, 2026 | -1.693 |
| December 31, 2025 | -1.395 |
| September 30, 2025 | -1.258 |
| June 30, 2025 | -1.200 |
| March 31, 2025 | -0.8119 |
| December 31, 2024 | -0.7192 |
| September 30, 2024 | -0.8494 |
| June 30, 2024 | -0.6159 |
| March 31, 2024 | -0.5568 |
| December 31, 2023 | -0.5771 |
| September 30, 2023 | -0.4532 |
| June 30, 2023 | -0.4554 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.7983 |
| December 31, 2022 | -1.167 |
| September 30, 2022 | -0.9068 |
| June 30, 2022 | -0.5485 |
| March 31, 2022 | -0.7052 |
| December 31, 2021 | -0.7918 |
| September 30, 2021 | -0.3577 |
| June 30, 2021 | -0.1615 |
| March 31, 2021 | -0.2216 |
| December 31, 2020 | -2.015 |
| September 30, 2020 | -0.2096 |
| June 30, 2020 | -0.1694 |
| March 31, 2020 | -0.1163 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -1.284 |
| Sarepta Therapeutics, Inc. | -0.2687 |
| Twist Bioscience Corp. | -0.316 |
| Oncolytics Biotech, Inc. | -0.0759 |
| Sangamo Therapeutics, Inc. | -0.0796 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -93.71M |
| Revenue (Quarterly) | 10.28M |
| Total Expenses (Quarterly) | 103.99M |
| Enterprise Value | 1.723B |
| Gross Profit Margin (Quarterly) | 62.84% |
| Profit Margin (Quarterly) | -911.9% |
| Earnings Yield | -21.92% |
| Normalized Earnings Yield | -21.92 |